These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26702838)

  • 1. Long-Segment Fusion for Adult Spinal Deformity Correction Using Low-Dose Recombinant Human Bone Morphogenetic Protein-2: A Retrospective Review of Fusion Rates.
    Schmitt PJ; Kelleher JP; Ailon T; Heller JE; Kasliwal MK; Shaffrey CI; Smith JS
    Neurosurgery; 2016 Aug; 79(2):212-21. PubMed ID: 26702838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic protein (RhBMP-2) as a substitute for iliac crest bone graft in multilevel adult spinal deformity surgery: minimum two-year evaluation of fusion.
    Mulconrey DS; Bridwell KH; Flynn J; Cronen GA; Rose PS
    Spine (Phila Pa 1976); 2008 Sep; 33(20):2153-9. PubMed ID: 18725869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long adult spinal deformity fusion to the sacrum using rhBMP-2 versus autogenous iliac crest bone graft.
    Maeda T; Buchowski JM; Kim YJ; Mishiro T; Bridwell KH
    Spine (Phila Pa 1976); 2009 Sep; 34(20):2205-12. PubMed ID: 19752707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RhBMP-2 is superior to iliac crest bone graft for long fusions to the sacrum in adult spinal deformity: 4- to 14-year follow-up.
    Kim HJ; Buchowski JM; Zebala LP; Dickson DD; Koester L; Bridwell KH
    Spine (Phila Pa 1976); 2013 Jun; 38(14):1209-15. PubMed ID: 23392417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iliac crest bone graft donor site pain after anterior lumbar interbody fusion: a prospective patient satisfaction outcome assessment.
    Sasso RC; LeHuec JC; Shaffrey C;
    J Spinal Disord Tech; 2005 Feb; 18 Suppl():S77-81. PubMed ID: 15699810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate.
    Baskin DS; Ryan P; Sonntag V; Westmark R; Widmayer MA
    Spine (Phila Pa 1976); 2003 Jun; 28(12):1219-24; discussion 1225. PubMed ID: 12811263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of TLIF with rhBMP-2 versus no TLIF and higher posterolateral rhBMP-2 dose at L5-S1 for long fusions to the sacrum with sacropelvic fixation in patients with primary adult deformity.
    Rahman RK; Buchowski JM; Stephens B; Dorward IG; Koester LA; Bridwell KH
    Spine (Phila Pa 1976); 2013 Dec; 38(26):2264-71. PubMed ID: 24108280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of bone morphogenetic protein-2 for adult spinal deformity.
    Luhmann SJ; Bridwell KH; Cheng I; Imamura T; Lenke LG; Schootman M
    Spine (Phila Pa 1976); 2005 Sep; 30(17 Suppl):S110-7. PubMed ID: 16138058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft.
    Dimar JR; Glassman SD; Burkus KJ; Carreon LY
    Spine (Phila Pa 1976); 2006 Oct; 31(22):2534-9; discussion 2540. PubMed ID: 17047540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
    Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
    Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
    Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
    Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and radiographic analysis of an optimized rhBMP-2 formulation as an autograft replacement in posterolateral lumbar spine arthrodesis.
    Dimar JR; Glassman SD; Burkus JK; Pryor PW; Hardacker JW; Carreon LY
    J Bone Joint Surg Am; 2009 Jun; 91(6):1377-86. PubMed ID: 19487515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Instrumented one and two level posterolateral fusions with recombinant human bone morphogenetic protein-2 and allograft: a computed tomography study.
    Stambough JL; Clouse EK; Stambough JB
    Spine (Phila Pa 1976); 2010 Jan; 35(1):124-9. PubMed ID: 20042965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
    Slosar PJ; Josey R; Reynolds J
    Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic morphogenetic protein vs. recombinant human bone morphogenetic protein-2 in lumbar interbody fusion procedures: a radiographic and economic analysis.
    Roh JS; Yeung CA; Field JS; McClellan RT
    J Orthop Surg Res; 2013 Dec; 8():49. PubMed ID: 24373225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of allograft and recombinant human bone morphogenetic protein for instrumented atlantoaxial fusions.
    Hood B; Hamilton DK; Smith JS; Dididze M; Shaffrey C; Levi AD
    World Neurosurg; 2014 Dec; 82(6):1369-73. PubMed ID: 23336983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies.
    Boden SD; Kang J; Sandhu H; Heller JG
    Spine (Phila Pa 1976); 2002 Dec; 27(23):2662-73. PubMed ID: 12461392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. rhBMP-2 for posterolateral instrumented lumbar fusion: a multicenter prospective randomized controlled trial.
    Hurlbert RJ; Alexander D; Bailey S; Mahood J; Abraham E; McBroom R; Jodoin A; Fisher C
    Spine (Phila Pa 1976); 2013 Dec; 38(25):2139-48. PubMed ID: 24296479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.